Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth M Benca

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 25, 2015
Effects of partial sleep deprivation on slow waves during non-rapid eye movement sleep: A high density EEG investigationDavid T Plante, Michael R Goldstein, Jesse D Cook, et al.
Neurobiology of Aging|June 11, 2015
Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adultsKate E Sprecher, Barbara B Bendlin, Annie M Racine, et al.
Neurology|July 7, 2017
Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adultsKate E Sprecher, Rebecca L Koscik, Cynthia M Carlsson, et al.
The American Journal of Psychiatry|September 21, 2019
Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical TrialWilliam V McCall, Ruth M Benca, Peter B Rosenquist, et al.
Postgraduate Medicine|August 12, 2009
Insomnia in primary care: panel discussionSonia Ancoli-Israel, Ruth M Benca, Paul P Doghramji, et al.
Journal of Sleep Research|December 1, 2020
Objective adherence to dental device versus positive airway pressure treatment in adults with obstructive sleep apneaLiyue Xu, Dawei Xie, Kara S Griffin, et al.
Journal of Sleep Research|August 3, 2018
Sleep disorders, depression and anxiety are associated with adverse safety outcomes in healthcare workers: A prospective cohort studyMatthew D Weaver, Céline Vetter, Shantha M W Rajaratnam, et al.
The Lancet. Neurology|April 1, 2014
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialDavid Michelson, Ellen Snyder, Erin Paradis, et al.
Psychopharmacology|March 8, 2017
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 dataW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 12, 2016
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical TrialsW Joseph Herring, Kathleen M Connor, Ellen Snyder, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 25, 2015
Effects of partial sleep deprivation on slow waves during non-rapid eye movement sleep: A high density EEG investigationDavid T Plante, Michael R Goldstein, Jesse D Cook, et al.
Neurobiology of Aging|June 11, 2015
Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adultsKate E Sprecher, Barbara B Bendlin, Annie M Racine, et al.
Neurology|July 7, 2017
Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adultsKate E Sprecher, Rebecca L Koscik, Cynthia M Carlsson, et al.
The American Journal of Psychiatry|September 21, 2019
Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical TrialWilliam V McCall, Ruth M Benca, Peter B Rosenquist, et al.
Postgraduate Medicine|August 12, 2009
Insomnia in primary care: panel discussionSonia Ancoli-Israel, Ruth M Benca, Paul P Doghramji, et al.
Journal of Sleep Research|December 1, 2020
Objective adherence to dental device versus positive airway pressure treatment in adults with obstructive sleep apneaLiyue Xu, Dawei Xie, Kara S Griffin, et al.
Journal of Sleep Research|August 3, 2018
Sleep disorders, depression and anxiety are associated with adverse safety outcomes in healthcare workers: A prospective cohort studyMatthew D Weaver, Céline Vetter, Shantha M W Rajaratnam, et al.
The Lancet. Neurology|April 1, 2014
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialDavid Michelson, Ellen Snyder, Erin Paradis, et al.
Psychopharmacology|March 8, 2017
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 dataW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 12, 2016
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical TrialsW Joseph Herring, Kathleen M Connor, Ellen Snyder, et al.
Pageof 12